Predictors of fetal hemoglobin response in children with sickle cellanemia receiving hydroxyurea therapy

Blood

Volumn 99, Issue 1, 2002, Pages 10-14

  Ware, Russell E ^a   Eggleston, Barry ^b   Redding Lallinger, Rupa ^b   Wang, Winfred C ^b   Smith Whitley, Kim ^b   Daeschner, Charles ^b   Gee, Beatrice ^b   Styles, Lori A ^b   Helms, Ronald W ^b   Kinney, Thomas R ^b   Ohene Frempong, Kwaku ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUMC ^*

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

EID: 0036096085     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.10     Document Type: Article

References (22)

1. Fetal hemoglobin, sickling, and sickle cell disease
2. Pain in sickle cell disease: Rates and risk factors
3. The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia
4. Mortality in children and adolescents with sickle cell disease
5. Mortality in sickle cell disease: Life expectancy and risk factors for early death
6. Treatment of sickle cell anemia with hydroxyurea and erythropoietin
7. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders
8. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
9. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia
10. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
11. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia
12. Hydroxyurea therapy in children severely affected with sickle cell disease
13. Hydroxyurea for the treatment of severe sickle cell anemia: A pediatric clinical trial
14. Three year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease
15. Hydroxyurea in children with sickle cell disease: Impact on splenic function and compliance with therapy
16. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial
17. Separation of hemoglobins
18. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia
19. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells
20. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy
21. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea
22. Fetal hemoglobin in sickle cellanemia: Determinants of response to hydroxyurea